Zelnorm (tegaserod), a new drug for irritable bowel syndrome
September 2002
Novartis is now marketing Zelnorm (tegaserod), a new drug for irritable bowel syndrome.
Zelnorm is the first in a new class...5-HT4 serotonin partial agonist. It STIMULATES bowel motility to reduce abdominal pain...bloating...and constipation. It's for CONSTIPATION-predominant IBS.
This is different from Lotronex, which is a 5-HT3 serotonin antagonist that SLOWS bowel motility...for DIARRHEA-predominant IBS.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote